Neurocrine Biosciences Inc (NBIX) insider trading.
In Q3 2026, insiders at Neurocrine Biosciences Inc reported 40 non-derivative transactions on 17 Forms 3, 4 and 5: 0 open-market purchases and 9 sales worth $6.2M.
- Transactions
- 40
- Purchases (P)
- 0
- Sales (S)
- 9
- Net shares, P minus S
- -35,479
- Insiders
- 12
- Last filed
- 2026-09-15
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Delaet Ingrid | Officer · Chief Regulatory Officer | 10 | 0 | 4 |
| Lippoldt Darin | Officer · Chief Legal Officer | 4 | 0 | 1 |
| Gano Kyle | Director, Officer · Chief Executive Officer | 4 | 0 | 0 |
| Benevich Eric | Officer · Chief Commercial Officer | 4 | 0 | 1 |
| Abernethy Matt | Officer · Chief Financial Officer | 3 | 0 | 1 |
| Boyer David W. | Officer · Chief Corp. Affairs Officer | 3 | 0 | 1 |
| Onyia Jude | Officer · Chief Scientific Officer | 3 | 0 | 0 |
| Gorman Kevin Charles | Director | 2 | 0 | 0 |
| Cooke Julie | Officer · Chief Human Resources Officer | 2 | 0 | 0 |
| Keswani Sanjay Chandru | Officer · Chief Medical Officer | 2 | 0 | 0 |
| Norwalk Leslie V | Director | 2 | 0 | 1 |
| Sherwin Stephen A | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-14 | Abernethy Matt | S (D) | 2,311 | $157.2 | 42,808 | Form 4 |
| 2026-09-14 | Boyer David W. | S (D) | 826 | $157.45 | 8,722 | Form 4 |
| 2026-09-11 | Gorman Kevin Charles | A (A) | 14,343 | $0 | 525,636 | Form 4 |
| 2026-09-11 | Gorman Kevin Charles | F (D) | 7,839 | $156.22 | 517,797 | Form 4 |
| 2026-09-11 | Lippoldt Darin | F (D) | 2,419 | $156.22 | 56,793 | Form 4 |
| 2026-09-11 | Lippoldt Darin | A (A) | 4,483 | $0 | 59,212 | Form 4 |
| 2026-09-11 | Gano Kyle | A (A) | 6,275 | $0 | 157,266 | Form 4 |
| 2026-09-11 | Gano Kyle | A (A) | 1,842 | $0 | 155,722 | Form 4 |
| 2026-09-11 | Gano Kyle | F (D) | 994 | $156.22 | 154,728 | Form 4 |
| 2026-09-11 | Gano Kyle | F (D) | 3,386 | $156.22 | 153,880 | Form 4 |
| 2026-09-11 | Benevich Eric | A (A) | 6,275 | $0 | 70,683 | Form 4 |
| 2026-09-11 | Benevich Eric | F (D) | 3,386 | $156.22 | 67,297 | Form 4 |
| 2026-09-11 | Abernethy Matt | F (D) | 2,709 | $156.22 | 45,119 | Form 4 |
| 2026-09-11 | Abernethy Matt | A (A) | 5,020 | $0 | 47,828 | Form 4 |
| 2026-09-11 | Cooke Julie | A (A) | 3,587 | $0 | 25,961 | Form 4 |
| 2026-09-11 | Cooke Julie | F (D) | 1,936 | $156.22 | 24,025 | Form 4 |
| 2026-09-11 | Keswani Sanjay Chandru | F (D) | 2,112 | $156.22 | 3,281 | Form 4 |
| 2026-09-11 | Keswani Sanjay Chandru | A (A) | 3,914 | $0 | 5,393 | Form 4 |
| 2026-09-11 | Onyia Jude | A (A) | 3,587 | $0 | 24,583 | Form 4 |
| 2026-09-11 | Onyia Jude | F (D) | 1,936 | $156.22 | 22,647 | Form 4 |
| 2026-09-11 | Boyer David W. | F (D) | 1,936 | $156.22 | 9,548 | Form 4 |
| 2026-09-11 | Boyer David W. | A (A) | 3,587 | $0 | 11,484 | Form 4 |
| 2026-09-11 | Delaet Ingrid | A (A) | 4,483 | $0 | 20,708 | Form 4 |
| 2026-09-11 | Delaet Ingrid | F (D) | 2,419 | $156.22 | 18,289 | Form 4 |
| 2026-09-09 | Benevich Eric | M (A) | 3,194 | $43.24 | 66,562 | Form 4 |
| 2026-09-09 | Benevich Eric | S (D) | 2,154 | $154.61 | 64,408 | Form 4 |
| 2026-09-02 | Sherwin Stephen A | G (D) | 1,000 | $0 | 14,860 | Form 4 |
| 2026-08-04 | Onyia Jude | G (D) | 2,409 | $0 | 20,996 | Form 4 |
| 2026-07-29 | Norwalk Leslie V | M (A) | 842 | $139.43 | 2,430 | Form 4 |
| 2026-07-28 | Norwalk Leslie V | S (D) | 1,250 | $182.01 | 1,588 | Form 4 |
| 2026-07-10 | Delaet Ingrid | M (A) | 4,367 | $106.02 | 20,592 | Form 4 |
| 2026-07-10 | Delaet Ingrid | S (D) | 4,367 | $181.02 | 16,225 | Form 4 |
| 2026-07-09 | Lippoldt Darin | M (A) | 10,000 | $81.49 | 64,729 | Form 4 |
| 2026-07-09 | Lippoldt Darin | S (D) | 10,000 | $179.6 | 54,729 | Form 4 |
| 2026-07-09 | Delaet Ingrid | M (A) | 8,433 | $103.52 | 24,658 | Form 4 |
| 2026-07-09 | Delaet Ingrid | S (D) | 8,433 | $178.72 | 16,225 | Form 4 |
| 2026-07-08 | Delaet Ingrid | S (D) | 2,737 | $178.54 | 16,225 | Form 4 |
| 2026-07-08 | Delaet Ingrid | M (A) | 2,737 | $103.52 | 18,962 | Form 4 |
| 2026-07-07 | Delaet Ingrid | M (A) | 3,401 | $103.52 | 19,626 | Form 4 |
| 2026-07-07 | Delaet Ingrid | S (D) | 3,401 | $178.57 | 16,225 | Form 4 |
Transaction codes in this quarter
Get NBIX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=914475&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · NBIX company page · Neurocrine Biosciences Inc on SEC.gov
Questions
Are insiders buying or selling Neurocrine Biosciences Inc (NBIX)?
In Q3 2026, insiders at Neurocrine Biosciences Inc reported 40 non-derivative transactions on 17 Forms 3, 4 and 5: 0 open-market purchases and 9 sales worth $6.2M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Neurocrine Biosciences Inc insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/nbix.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.